U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070518) titled 'Study of GV20-0251 in Participants With Solid Tumor Malignancies' on June 26.
Brief Summary: This is a Phase 1 and Phase 2 study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved therapies or other standard of care.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Solid Tumor Cancer
Adult Refractory Cancer
Endometrial Carcinoma (EC)
Squamous Head and Neck Carcinoma
pMMR/MSS Adenocarcinoma of the Colon or Rectum
Non-Small Cell Lung Cancer
Melanoma
HCC - Hepatocellular Carcinoma
Small Cell Lung Cancer
Intervention:
DRUG: GV20-0251
Part A: Inc...